PSYC 181 Lecture 5
Nicotine Fundamentals and Historical Trends
Definition and Psychoactive Role:
Nicotine is the primary psychoactive component found in tobacco and cigarettes.
While tobacco contains numerous chemical compounds, nicotine is the specific substance responsible for the psychoactive and physiological effects traditionally associated with smoking.
Carcinogenic Nature:
Nicotine itself is a direct carcinogen capable of causing cancer.
Compared to the extensive array of other carcinogenic substances present in tobacco leaf and combustible cigarette smoke, nicotine's individual carcinogenic impact is lower relative to the aggregate chemical toxicity.
Historical Trends in Cigarette Consumption:
Around the year , per capita cigarette consumption began a steady upward trajectory.
This surge coincided with the invention and commercialization of a novel paper wrapper that burned significantly slower, making cigarettes easier to smoke and maximizing the systemic absorption of nicotine and smoke.
Initial per capita intake was approximately cigarettes per year (equivalent to roughly cigarettes per day per person on average).
At the peak of cigarette usage, average per capita consumption exceeded cigarettes per day per person (approximately cigarettes per capita annually).
Scientific evidence establishing a direct link between cigarette smoking and cancer emerged as early as the 1950s.
Tobacco corporations engaged in aggressive public relations and legal pushback, conducting internal, biased studies designed to produce motivated conclusions asserting product safety.
By the mid-1960s, a broad, undeniable scientific consensus was established affirming that smoking causes cancer.
Historically, men consumed the vast majority of cigarettes and occupied dominant societal and institutional positions of power. Their personal enjoyment of smoking created significant institutional reluctance to officially recognize smoking as carcinogenic.
A steep decline in consumption occurred towards the turn of the 21st century, driven by an influx of anti-smoking public service campaigns and a doubling of the federal/state cigarette tax, making smoking economically prohibitive for many individuals.
Modern cigarette consumption has dropped back down to approximately cigarettes per capita per year.
Per capita cigarette metrics do not reflect alternative nicotine delivery methods such as electronic cigarettes (vapes) or oral nicotine pouches (e.g., Zyns, Lucies). Overall nicotine consumption across all delivery modalities may currently be higher than cigarette-only statistics indicate.
Nicotine Pharmacokinetics, Routes of Administration, and Metabolism
Primary Route of Administration and Delivery Acceleration:
Smoking represents the predominant route of nicotine administration.
Cigarettes are engineered with chemical additives designed to alter the pH level of the lung surface. Lowering the surface ionization keeps nicotine in a non-ionized state, allowing rapid transmucosal and pulmonary absorption.
Onset Velocity and Bioavailability:
Nicotine delivered via smoking reaches the brain with extreme speed, comparable to an intravenous (IV) injection.
Possesses an exceptionally high bioavailability upwards of , meaning of the inhaled drug successfully enters systemic circulation and reaches target tissue sites.
A single administration event (defined as one puff, drag, or hit) causes blood nicotine levels to max out within approximately and remain elevated for about .
Spacing hits apart yields substantially stronger subjective effects due to receptor recovery, whereas chain smoking leads to diminished acute effects due to rapid receptor desensitization.
Smoker Efficiency and Behavioral Variables:
The subjective experience and absorbed dose depend heavily on individual smoker features.
Experienced smokers possess greater smoking efficiency, taking deeper, longer inhalations and larger drags to maximize drug yield per administration.
Addictive Potential:
The combination of rapid onset, high bioavailability, and short duration of action directly correlates with maximum addictiveness and reinforcement.
Pharmaceutical design aimed at reducing addiction potential focuses on delaying onset speed and prolonging the duration of drug action.
Alternative Routes of Administration:
Chewing tobacco and dry snuff are absorbed transmucosally through the buccal membranes of the mouth and nasal passages.
Translocation Across Biological Barriers:
Absorbed nicotine readily crosses both the blood-brain barrier (BBB) and the placental barrier, posing severe teratogenic and developmental risks to a developing fetus.
High Frequency of Administration Events:
Nicotine is characterized by a higher frequency of repeated administrations than almost any other drug of abuse.
Every single hit or drag constitutes a discrete administration event; a single cigarette or vape pod contains dozens of individual doses, embedding exceptionally strong behavioral habit loops.
Metabolic Pathways and Half-Life:
Nicotine possesses an elimination half-life of approximately and is rapidly degraded by the liver.
The primary metabolite of nicotine is cotinine.
Urinalysis in smoking cessation and outpatient/inpatient addiction programs specifically assays for cotinine to verify abstinence.
Factors Influencing Metabolic Rate:
Preceding Meals: Consuming a meal prior to nicotine administration significantly accelerates nicotine metabolism. Unlike oral drugs (where food delays absorption and breakdown), eating jumpstarts systemic metabolic processes, causing nicotine to be broken down rapidly in the metabolic crossfire.
Estrogen Levels: Higher circulating estrogen levels (in biological females or individuals undergoing estrogen replacement therapy) induce hepatic enzymes that break down nicotine faster.
Menthol: Menthol (the cooling additive found in menthol cigarettes and flavored vapes like "strawberry ice") inhibits the specific liver enzyme induced by estrogen, directly decreasing the rate of nicotine metabolism.
Genetic Variation: Natural genetic polymorphisms create wide baseline differences in metabolic rate across the population.
Excretion and Renal Dynamics:
Nicotine is excreted primarily via urine, and elimination is heavily governed by urinary pH.
Acidic urine ionizes nicotine molecules, preventing them from being reabsorbed across renal tubules back into the bloodstream, thereby accelerating elimination.
Basic (alkaline) urine keeps nicotine non-ionized, facilitating renal tubular reabsorption and prolonging drug systemic presence.
Nicotine and cotinine are actively excreted into breast milk, exposing nursing infants to functional drug levels.
Nicotine Pharmacodynamics and Receptor Mechanisms
Primary Mechanism of Action:
Nicotine functions as a direct agonist at nicotinic acetylcholine receptors (nAChRs), selectively binding to and activating them across both the central nervous system (CNS) and peripheral nervous system (PNS).
Receptor Architecture:
Nicotinic acetylcholine receptors feature a pentameric structure, consisting of protein subunits surrounding a central ion channel pore.
Binding of nicotine induces a conformational change that opens all connected ion channels simultaneously.
Postsynaptic vs. Presynaptic Mechanisms:
Postsynaptic nAChRs: Channel opening permits an influx of positively charged Sodium () and Potassium () ions into the cell. This inward positive ion current depolarizes and excites the postsynaptic neuron, increasing its likelihood of firing an action potential.
Presynaptic nAChRs: Channel opening permits an influx of Calcium () ions into the axon terminal, directly triggering exocytosis and causing synaptic vesicles to fuse with the terminal membrane and spill their neurotransmitter contents into the synaptic cleft.
Receptor Subtype Diversity:
Subtype composition dictates receptor sensitivity to nicotine, specific ion conductance rates, channel opening speed, and overall drug-reinforcing potential.
nAChR activation enhances attentional processes, focus, and memory consolidation (explaining historical usage among writers).
Neurobiology of Nicotine Tolerance, Neurotransmission, and Physiological Effects
Tolerance Profiles and Receptor Upregulation:
Acute Tolerance: Develops rapidly within a single session or bout of repeated drug administration. Driven by fast nAChR desensitization. Subjective feelings of intoxication wear off long before the drug is cleared from systemic circulation.
Functional (Long-Term) Tolerance: Sustained receptor desensitization prompts the brain to upregulate (synthesize and insert more nAChRs into neuronal membranes).
Overnight Resensitization (Morning Phenomenon): During overnight sleep (a prolonged stretch of non-administration and withdrawal), desensitized receptors recover. Combined with the higher baseline density of upregulated receptors, the first nicotine dose in the morning encounters an abundance of available, sensitive receptors, producing a dramatically stronger subjective hit than doses taken later in the day.
Withdrawal symptoms and psychological cravings upon quitting are directly driven by this elevated pool of un-gated, upregulated receptors.
Central Nervous System (CNS) Effects and Brain Regions:
Prefrontal Cortex (PFC): Activation of local nAChRs enhances executive functioning, working memory, and focused attention.
Nucleus Accumbens and Ventral Tegmental Area (VTA): Core structures of the mesolimbic reward system. Nicotine stimulates these areas to release dopamine, mediating the primary rewarding and addictive properties of the drug.
Medullary Emetic Centers: High doses of nicotine stimulate central vomiting centers. Unaccustomed users taking high doses (e.g., consuming four oral nicotine pouches simultaneously) experience severe nausea and emesis.
Peripheral Nervous System (PNS) Effects:
Somatic Motor System: Modulates voluntary motor movements; high doses induce muscle weakness and fine motor tremors.
Autonomic Dual Action: Affects both sympathetic and parasympathetic nervous systems:
Sympathetic-like (Stimulant) Effects: Increased heart rate, elevated blood pressure, and peripheral vasoconstriction.
Parasympathetic-like Effects: Increased stomach acid secretion and heightened gastrointestinal motility (acting as a laxative and suppressing appetite).
Therapeutic Profile, Health Risks, Vaping, and Pesticides
Therapeutic Benefits (Low Dose):
Improves fine motor abilities, sustained attention, short-term memory, and working memory response latency (reduces response time, though without necessarily increasing accuracy).
Promotes gut motility, making it historically usable to treat refractory constipation.
Health Risks and Cons:
Potent carcinogen directly implicated in pathology.
Induces cardiovascular injury, pulmonary disease, heightened stress responses, and systemic vascular strain.
Electronic Cigarettes (Vapes):
Operation: An internal atomizer heats and vaporizes a liquid nicotine solution into an aerosolized vapor.
Concentration: Common nicotine solution concentrations range from to .
Comparison with Cigarettes: A conventional cigarette contains roughly of nicotine but delivers only about systemically due to side-stream smoke and combustion destruction. Vapes deliver highly concentrated nicotine without combustion loss.
Behavioral Patterns: The absence of harsh tobacco smoke odor permits frequent indoor use, leading to near-continuous administration throughout the day.
Cartridge Yield: One vape pod/cartridge contains total nicotine roughly equivalent to of combustible cigarettes, but higher efficiency and frequency yield greater total absorbed doses.
Flavorings and Marketing: Flavor additives (e.g., pina colada, fruit) enhance palatability and appeal to youth. State-level bans (e.g., California banning all flavored tobacco and menthol) target these youth-oriented marketing tactics.
Safety Profile: Vapes eliminate heavy combustion tar and specific smoke carcinogens (making them technically safer than cigarettes), but they are not healthy. The long-term health effects of inhaling aerosolized propylene glycol, vegetable glycerin, and chemical flavorings remain unknown.
Nicotine Withdrawal and Toxicity:
Withdrawal: Non-lethal compared to alcohol or sedatives, but intensely stressful psychologically. Onset occurs within of cessation, peaking at .
Toxicity: Highly toxic alkaloid. Historically utilized as an agricultural pesticide but phased out due to high toxicity to non-target mammals and humans.
Secondhand Smoke: Inhaling passive environmental smoke causes approximately deaths per year in the United States.
Thirdhand Smoke: Toxic nicotine and chemical residue that settles into household dust, carpets, and wall surfaces over months of indoor smoking, creating long-term toxic contact exposure.
Pesticide Toxicology and Nerve Agents:
Historical Shift: Widespread chemical safety assumptions were shattered by the Love Canal disaster (a suburban community built over a toxic chemical landfill leading to severe birth defects in children), prompting the creation of the Environmental Protection Agency (EPA).
Organochloride Pesticides (e.g., DDT): Function as non-selective Sodium () channel blockers. Extremely persistent in the environment. Blocking sodium channels prevents neuronal action potentials, causing paralysis, respiratory arrest, and death.
Organophosphate Pesticides: Function as acetylcholinesterase (AChE) inhibitors. Less environmental persistence than organochlorides, but cause toxic synaptic accumulation of acetylcholine. Designed to be selective for insect AChE, but high accumulated doses induce severe neurotoxicity, seizures, and death in humans and animals.
Nerve Agents / Chemical Warfare: Potent, irreversible AChE inhibitors (e.g., mustard gas, sarin gas). Cause extreme skin blistering, airway destruction, choking, convulsions, and death. Phased out internationally due to horrific lethality and indiscriminate civilian casualties.
Prominent Attacks: 1995 Tokyo subway attack by the Aum Shinrikyo cult using sarin gas (killed ~ people); Ghouta, Syria attack by the Assad regime using sarin gas.
Methylxanthines and Caffeine Pharmacokinetics
Class Definition:
Caffeine belongs to a chemical class called the methylxanthines.
Related methylxanthines include theophylline (a vasodilator used in prescription asthma inhalers) and theobromine (a bronchodilator also used in asthma management).
Discovery and History:
First isolated from coffee beans by a German chemist, who initially named the isolated substance "coffee base."
Global Prevalence:
Caffeine is the most widely consumed psychoactive drug in the world.
Used regularly by approximately of the global population, and over of the population in the United States.
Daily Consumption Statistics:
Average US daily intake is approximately (equivalent to about standard cups of coffee).
Daily intake exceeding enters unsafe clinical levels.
Diagnostic Status:
There is no diagnostic classification for "Caffeine Use Disorder" in the DSM.
Substance use disorders require functional impairment within a social context; caffeine consumption is culturally normative and socially accepted.
Routes of Administration:
Almost exclusively administered orally.
Medical applications utilize intramuscular (IM) injection, intravenous (IV) injection, or rectal suppositories (pills) to bypass gastrointestinal upset in sensitive patients or children.
Medical Uses:
Treating vascular migraine headaches, enhancing alertness, stimulating gut motility in constipation, and inclusion in topical skincare/transdermal creams (targeting cellulite and hair restoration via localized vasodilation).
Absorption and Distribution:
Lipid Solubility: Highly lipid-soluble. Approximately is absorbed and cleared from the stomach within .
Food Interaction: Co-ingestion with food slows down caffeine absorption and metabolic rate (opposite of nicotine).
Barrier Translocation: Effortlessly crosses the blood-brain barrier (BBB) and placental barrier. Doses during pregnancy constrict placental blood vessels, reducing blood flow and stunting embryonic growth.
Metabolism and Elimination:
Peak plasma concentrations of metabolites occur post-ingestion.
Nearly is metabolized by hepatic enzymes in the liver; only about is excreted unchanged in urine.
Elimination half-life ranges from across individuals.
At high doses (), hepatic clearance enzymes become saturated, significantly prolonging the elimination half-life.
Pharmacodynamics of Caffeine and Neurotransmitter Modulation
Primary Mechanism of Action:
Functions as a direct adenosine receptor antagonist, specifically blocking the and adenosine receptor subtypes.
Endogenous Role of Adenosine:
Adenosine is an endogenous neuromodulator that builds up continuously throughout waking hours, binding to its receptors to produce sedation and sleepiness.
Caffeine blocks adenosine from binding to its receptors, preventing adenosine-mediated sedation and resulting in heightened vigilance and wakefulness.
Receptor Subtype Localization:
Receptors: Highly concentrated in dopamine-rich brain regions (e.g., nucleus accumbens, striatum).
Receptors: Widely distributed throughout the cerebral cortex.
Presynaptic Heteroreceptors vs. Autoreceptors:
Autoreceptors: Presynaptic receptors that bind neurotransmitters released by the same presynaptic cell, functioning as a negative-feedback brake on release.
Heteroreceptors: Presynaptic receptors that bind neurotransmitters or ligands released by other nearby cells or exogenous drugs.
Adenosine Heteroreceptor Mechanism: Adenosine normally binds presynaptic heteroreceptors to inhibit neurotransmitter release.
Caffeine Disinhibition: Caffeine blocks adenosine at these heteroreceptors. Removing adenosine's inhibitory signal causes a net increase in presynaptic release across multiple neurotransmitter systems:
Acetylcholine (ACh): Increased release enhances cortical attention and vigilance.
Glutamate: Increased release elevates cortical excitability; massive doses over-excite circuits, presenting a severe risk of seizures (e.g., Panera Charged Lemonade fatalities).
Dopamine: Increased release elevates baseline motor activity and mild reward.
Norepinephrine & Serotonin: Increased release elevates autonomic arousal and mood processing.
Receptor Mosaics:
Definition: Physical protein complexes formed by two or more distinct receptor types linked such that activity at one receptor directly influences the conformation and signaling of the adjacent receptor.
Adenosine-Dopamine Mosaics: Caffeine binding to the adenosine portion of an mosaic directly alters the attached dopamine receptor, enhancing dopaminergic neurotransmission through a direct physical interaction separate from heteroreceptor disinhibition.
Systemic Consequences, Intoxication, and Toxicity of Caffeine
Systemic Physiological Effects:
Adrenal Activation: Stimulates epinephrine (adrenaline) release from the adrenal glands, driving sympathetic responses (elevated body temperature, increased heart rate, heightened muscle tone — rendering caffeine a primary component in pre-workout formulations).
Vascular Effects: Induces differential vasodilation and vasoconstriction, alleviating vascular headache pain.
Sensory Disturbances: Massive intake ( of coffee) induces auditory tinnitus (ringing in the ears) and visual disturbances (flashing lights).
Caffeine Intoxication (DSM Criteria):
Requires recent ingestion well in excess of (severe intoxication escalates past ).
Symptoms include restlessness, nervousness, excitement, insomnia, facial flushing, diuresis, gastrointestinal disturbance, muscle twitching, tachycardia, and psychomotor agitation.
Circadian Timing and Anxiogenesis:
Delaying caffeine consumption by approximately post-waking yields superior alertness by allowing baseline adenosine clearance without blunting natural cortisol waking spikes.
Doses consistently exert anxiogenic (anxiety-producing) effects.
Pros and Cons:
Correlational Health Benefits: Regular moderate caffeine intake correlates with lower risks of type 2 diabetes and reduced incidence of several cancers.
Cons: Disrupts sleep architecture, elevates baseline heart rate, and causes cardiovascular strain.
Withdrawal Profile: Sets in at daily doses as low as ( of coffee). Begins ~ post-cessation; symptoms include throbbing headaches, extreme fatigue, dysphoria, and impaired concentration. Tapering doses attenuates withdrawal severity.
Lethality:
Lethal dose is approximately (), though fatalities occur at doses as low as ().
is equivalent to drinking of standard coffee or rapidly consuming energy shots ().
Psychomotor Stimulants: Formulations and Routes of Administration
Class Overview:
Psychomotor stimulants produce dual effects: "psycho" (arousal, heightened alertness, euphoria) and "motor" (increased bodily locomotion, fidgeting, motor agitation).
They potentate monoaminergic neurotransmission, directly mimicking the sympathetic fight-or-flight response.
Amphetamines and Methamphetamine (Synthetic):
Amphetamine: Prescribed oral formulations reach peak systemic levels in ~. Recreational intranasal, inhalation, or IV routes produce vastly accelerated onset times.
Methamphetamine: A potent chemical analogue. The abused formulation, crystal meth, is a highly purified, smokeable crystalline form.
Precursor Restriction: Synthesized using pseudoephedrine (formerly abundant in Sudafed). Legal regulations limit individual monthly purchases to , tracked via mandatory state and national pharmacy registry logs.
Pharmacokinetic Superiority of Crystal Meth: Rapidly penetrates the blood-brain barrier when smoked, resists metabolic degradation, and produces intense effects lasting for many hours (substantially longer than cocaine).
Cocaine (Naturally Occurring):
Botanical Source and Formulations:
Coca Paste: Crude extraction from crushed coca leaves combined with kerosene and lime. Cheap, smoked on tobacco, highly chemically unstable, and unsuitable for long-distance trafficking.
Cocaine Hydrochloride: The refined salt form (white powder). Highly stable for international trafficking. Manufactured in South America; cheaper in the US than Europe due to shorter transit routes (whereas Middle Eastern heroin is cheaper in Europe than the US).
Crack Cocaine: Freebase cocaine extracted from hydrochloride salt using ammonia and baking soda. Heating the precipitate frees the cocaine base, producing audible crackling sounds. Highly volatile and potent when vaporized/smoked.
Temporal Profile Comparison (Same Route): Cocaine penetrates the brain in half the time of amphetamines, reaches higher brain concentrations, and clears rapidly. Subjective effects persist for only ~ (versus for amphetamines).
Mechanisms of Action: Amphetamines versus Cocaine
Monoamine Transporters and Enzymes:
Monoamine Transporters (MATs): Transmembrane proteins (DAT, SERT, NET) that clear monoamines from the synaptic cleft back into the presynaptic terminal.
Vesicular Monoamine Transporters (VMATs): Membrane proteins that pump cytoplasmic monoamines into storage vesicles within axon terminals.
Monoamine Oxidase (MAO): Intracellular and synaptic enzyme that degrades monoamines.
Amphetamine / Methamphetamine Mechanism (4-Step Process):
Amphetamines structurally mimic monoamines and enter the presynaptic terminal via MAT uptake.
Once inside, amphetamines reverse the action of VMATs, forcing monoamines out of storage vesicles into the presynaptic cytoplasm.
The massive build-up of unsequestered monoamines in the cytoplasm forces the MATs to run in reverse, pumping monoamines out of the cytoplasm directly into the synaptic cleft.
Amphetamines concurrently inhibit MAO, blocking enzymatic degradation of monoamines in the cleft.
Net Result: Massive, non-exocytotic surge of dopamine, norepinephrine, and serotonin in the synaptic cleft.
Cocaine Mechanism (Reuptake Blockade):
Directly binds to and blocks MATs (DAT, SERT, NET), preventing monoamine reuptake.
Monoamines accumulate in the synaptic cleft solely as a consequence of ongoing exocytosis paired with blocked clearance.
Short-Term, Long-Term, and Route-Specific Consequences of Psychomotor Stimulants
Short-Term Effects:
Euphoria, exhilaration, heightened attention, reduced fatigue, profound appetite suppression (anorectic effect), increased respiration, bronchodilation, and sympathomimetic responses (hypertension, tachycardia, peripheral vasoconstriction, and hypothermia risks).
Biphasic Dose Response (U-Shaped Curve):
Low/Therapeutic Doses: Enhance executive control, sharpen attention, and reduce impulsivity (basis for ADHD treatment).
High/Abused Doses: Impair executive control, promote profound impulsivity, hyper-reactivity, cognitive deficits, and memory loss.
Long-Term Effects:
Severe anxiety, sexual dysfunction, chronic insomnia, severe weight loss, motor impairment, neurotoxicity, aggressive behavior, and paranoia.
Organ System Pathology by Route of Administration:
Intranasal (Snorting): Chronic vasoconstriction causes ischemic necrosis of nasal tissue, nosebleeds, loss of smell, perforated septum, and potential total nasal collapse/amputation.
Inhalation (Smoking): Pulmonary disease, asthma, chronic cough, severe respiratory distress.
Oral: Reduced mesenteric blood flow causes severe bowel ischemia and gangrene. Inhibited salivation (extreme dry mouth) causes rapid, severe dental caries ("meth mouth") and periodontal decay; systemic sepsis from rotted teeth can be fatal.
Intravenous (IV): Blood-borne pathogen transmission (HIV, Hepatitis C), vein collapse, endocarditis, and elevated risk-taking behaviors.
Cocaine vs. Amphetamine Distinctions:
Duration & Binge Frequency: Cocaine's brief half-life (~) drives compulsive re-administration ("bingeing") every , whereas amphetamine effects persist for .
Cardiovascular Severity: Cocaine poses substantially higher acute risks of myocardial infarction (heart attack), stroke, and lethal cardiac dysrhythmias.
Convulsive Effects: Cocaine lowers seizure thresholds; seizure effects sensitize over time, occurring at progressively lower doses.
Local Anesthetic Action: Unique to cocaine among stimulants. Directly blocks voltage-gated Sodium () channels, arresting nerve action potential conduction. Synthetic derivatives (Lidocaine, Novocaine) preserve channel blockade for anesthesia without inhibiting monoamine reuptake, eliminating stimulant and addictive properties.
Medical Applications, Tolerance Dynamics, and Toxicity of Stimulants
Therapeutic Applications:
Amphetamines:
ADHD Treatment: Account for ~ of pediatric ADHD prescriptions (the remaining are methylphenidate/Ritalin). Although amphetamine is clinically safer than methylphenidate, parental stigma surrounding the word "amphetamine" limits pediatric prescription; adult ADHD treatment favors amphetamines. Therapeutic oral doses () are vastly lower than abused doses ( of methamphetamine).
Pediatric Growth Management: Anorectic effects do not show tolerance. Appetite suppression can stunt childhood growth; pediatric patients are managed with weekend/summer drug holidays and occasional co-prescriptions of human growth hormone (HGH).
Historical Uses: Obesity (anorectic effect), clinical depression (phased out for superior agents), and narcolepsy.
Cocaine:
Topical surgical anesthetic and hemostatic agent in mucosal (nasal, ocular) surgeries, leveraging its dual local anesthetic and vasoconstrictive properties to stop surgical bleeding. Replaced largely by lidocaine due to cardiac risks.
Tolerance and Sensitization Profiles:
Acute Tolerance & "Coking Out": Repeated cocaine administration every over several hours causes complete loss of subjective euphoria due to rapid receptor/DAT desensitization ("coked out"). Subjective sensitivity resets within ~.
Dangerous Dissociation: Acute tolerance develops to subjective euphoria, but not to cardiovascular strain. Users escalating doses to achieve a high invite catastrophic cardiovascular collapse.
Long-Term Tolerance: Develops to autonomic effects (hypertension leads to arterial wall hardening, non-pliability, and rupture risks) and anorectic effects.
Sensitization Profile: Sensitization (increased responsiveness) develops to psychomotor activation, rewarding properties, and psychomimetic effects (stimulant psychosis: paranoid delusions, hallucinations, and formication/hallucinations of insects crawling under skin, mimicking paranoid schizophrenia).
Unchanging Effects: Sleep disturbance shows neither tolerance nor sensitization.
Lethality and Overdose:
Tolerance to lethal effects widens lethal dose ranges tremendously: Cocaine lethal dose ranges from (non-tolerant) to (tolerant); Amphetamine ranges from to .
Cocaine Overdose Phases:
Phase 1: Hyper-excitement, severe headache, nausea, hyperthermia, tremors, and violent clonic-tonic convulsions/seizures.
Phase 2: Loss of consciousness, central respiratory depression, cardiac dysrhythmias, and cardiac arrest.
Amphetamine Overdose Profile: Mydriasis (dilated pupils), severe shivering, malignant hyperthermia, severe hypertension, chest pain, and cerebrovascular accidents.
Public Health Campaigns ("Faces of Meth"):
Law enforcement initiative analyzing mugshots of chronic methamphetamine addicts over extended timeframes (e.g., a interval) to demonstrate rapid physical decay.
Pathological Features: Premature facial aging, open facial sores/lesions (caused by compulsive skin picking triggered by formication combined with ischemic skin decay), and rampant dental rot ("meth mouth").
Questions and Discussion
Question: Why is nicotine considered a highly addictive drug when smoked?
Answer: It reaches the brain rapidly (almost as fast as an IV injection) and possesses an extremely high bioavailability upwards of .
Question: What happens when nicotine binds to a postsynaptic nicotinic receptor?
Answer: The receptor's pentameric channel opens, allowing Sodium () and Potassium () ions to flow into the cell, depolarizing and exciting the cell.
Question: Why does the first cigarette of the day produce significantly stronger effects than later cigarettes?
Answer: Overnight sleep provides a long period of non-administration, allowing desensitized receptors to recover and leaving a higher total pool of available, sensitized receptors ready to bind nicotine.
Question: Is there a specific function of the prefrontal cortex that nicotine impacts?
Answer: Nicotine activates nicotinic acetylcholine receptors located within the prefrontal cortex, enhancing the attentional, executive, and working memory processes mediated by that region.
Question: Is nicotine itself healthy compared to tar/heavy metals in cigarettes, and does switching to vapes/pouches make someone completely healthy?
Answer: Nicotine itself is a direct carcinogen and causes cardiovascular strain. While switching to smokeless vapes or pouches eliminates heavy combustion tar and is technically less harmful, it is not completely healthy or risk-free.
Question: Do physicians actually prescribe cigarettes for constipation?
Answer: Cigarettes are no longer prescribed because superior alternative laxative medications exist, though increased gut motility remains an established physiological effect of nicotine.
Question: Is cannabis smoke a carcinogen compared to cigarette smoke?
Answer: Combustion of any plant material generates carcinogenic pyrolytic compounds in smoke. However, tobacco smoke contains far more carcinogens than cannabis smoke, and while nicotine itself is a carcinogen, whether THC itself is carcinogenic remains heavily disputed (with broader consensus indicating it is not).
Question: What is one major concern regarding e-cigarette use?
Answer: E-cigarettes are relatively new, meaning the long-term health consequences of inhaling aerosolized liquid solution components (propylene glycol, vegetable glycerin) are entirely unknown.
Question: How do researchers determine deaths caused by secondhand smoke?
Answer: By identifying tobacco and nicotine metabolites (such as cotinine) in the systems of deceased individuals who were confirmed non-smokers.
Question: Why are organochloride pesticides like DDT considered dangerous?
Answer: They act as non-selective sodium channel blockers, persist in the environment for decades without breaking down, and are highly toxic to humans and non-target animals.
Question: Which drug is the most widely used psychoactive substance in the world?
Answer: Caffeine.
Question: Why is caffeine able to cross the blood-brain barrier so easily?
Answer: It possesses high lipid solubility, allowing it to diffuse directly across lipid bilayer cell membranes.
Question: What type of drug action does caffeine exert at adenosine receptors?
Answer: It acts as a direct receptor antagonist at and adenosine receptors.
Question: Why does caffeine sometimes make individuals with ADHD feel sleepy?
Answer: This represents an idiosyncratic drug response driven by individual genetic variations in adenosine pathways, baseline neurochemical differences, or active interactions with co-administered ADHD stimulant medications.
Question: What is the fundamental difference between presynaptic autoreceptors and heteroreceptors?
Answer: Autoreceptors bind neurotransmitters released by the same presynaptic cell (acting as a self-regulating brake), whereas heteroreceptors bind neurotransmitters or ligands released by other nearby cells or exogenous drugs.
Question: How does caffeine indirectly increase acetylcholine release?
Answer: Caffeine acts as an antagonist at presynaptic adenosine heteroreceptors, blocking adenosine's normal inhibitory signal and thereby disinhibiting (increasing) acetylcholine release.
Question: How does the route of administration alter amphetamine's onset of action?
Answer: Therapeutic oral administration requires approximately to reach peak concentration, whereas recreational routes (intranasal, inhalation, IV) produce intense effects in approximately or less.
Question: How do the subjective effects of cocaine compare to amphetamines?
Answer: Subjective euphoric effects of cocaine dissipate rapidly within ~, whereas the subjective effects of amphetamines persist for up to or longer.
Question: What specific bodily effects does methamphetamine produce?
Answer: It produces potent sympathomimetic effects, activating the sympathetic nervous system to induce fight-or-flight responses (hypertension, tachycardia, vasoconstriction, rapid respiration).
Question: How does cocaine's impact on the cardiovascular system compare to amphetamines?
Answer: Cocaine exerts substantially stronger cardiovascular toxicity, dramatically increasing acute risks of myocardial infarction, stroke, aortic rupture, and lethal cardiac dysrhythmias.
Question: How does tolerance influence the lethal dose threshold of psychomotor stimulants?
Answer: Repeated administration leads to profound tolerance against lethal effects, creating an extremely broad range between lethal doses for novel users versus chronic, highly tolerant users.